JP2002516616A - 活性成分として単数または複数の抗感染症薬と微生物とを含む安定な固定薬用量の医薬組成物の製造法 - Google Patents

活性成分として単数または複数の抗感染症薬と微生物とを含む安定な固定薬用量の医薬組成物の製造法

Info

Publication number
JP2002516616A
JP2002516616A JP54906699A JP54906699A JP2002516616A JP 2002516616 A JP2002516616 A JP 2002516616A JP 54906699 A JP54906699 A JP 54906699A JP 54906699 A JP54906699 A JP 54906699A JP 2002516616 A JP2002516616 A JP 2002516616A
Authority
JP
Japan
Prior art keywords
infective
composition
stable
coating
drug
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
JP54906699A
Other languages
English (en)
Japanese (ja)
Inventor
ラジブ インドラバダン モディ
ヤティシュ クマル バンサル
バクレシュ マファトラル カマル
Original Assignee
カディラ ファーマシューティカルズ（イー．アー．）リミテッド
ラジブ インドラバダン モディ
ヤティシュ クマル バンサル
バクレシュ マファトラル カマル
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9806489.2A external-priority patent/GB9806489D0/en
Application filed by カディラ ファーマシューティカルズ（イー．アー．）リミテッド, ラジブ インドラバダン モディ, ヤティシュ クマル バンサル, バクレシュ マファトラル カマル filed Critical カディラ ファーマシューティカルズ（イー．アー．）リミテッド
Publication of JP2002516616A publication Critical patent/JP2002516616A/ja
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/062—Ascomycota
    • A61K36/064—Saccharomycetales, e.g. baker's yeast
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
JP54906699A 1998-03-27 1998-04-03 活性成分として単数または複数の抗感染症薬と微生物とを含む安定な固定薬用量の医薬組成物の製造法 Ceased JP2002516616A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
LK9806489.2 1998-03-27
GBGB9806489.2A GB9806489D0 (en) 1998-03-27 1998-03-27 The process for the preparation of a stable fixed dose pharmaceutical composition of anti-infective agent/agents and micro organisms as active ingredients
LK16445 1998-03-27
LK1644598 1998-03-27
PCT/IB1998/000445 WO1999049875A1 (en) 1998-03-27 1998-04-03 The process for the preparation of a stable fixed dose pharmaceutical composition of anti infective agent/agents and micro organisms as active ingredients

Publications (1)

Publication Number Publication Date
JP2002516616A true JP2002516616A (ja) 2002-06-04

Family

ID=26313367

Family Applications (1)

Application Number Title Priority Date Filing Date
JP54906699A Ceased JP2002516616A (ja) 1998-03-27 1998-04-03 活性成分として単数または複数の抗感染症薬と微生物とを含む安定な固定薬用量の医薬組成物の製造法

Country Status (9)

Country Link
EP (1) EP0998295A1 (uk)
JP (1) JP2002516616A (uk)
AP (1) AP9901724A0 (uk)
AU (1) AU770024B2 (uk)
CA (1) CA2291780A1 (uk)
EA (1) EA002148B1 (uk)
ID (1) ID26341A (uk)
UA (1) UA59394C2 (uk)
WO (1) WO1999049875A1 (uk)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2012511572A (ja) * 2008-12-10 2012-05-24 アルファーマ，エルエルシー 動物における病気を制御する組成物および方法

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0916335D0 (en) * 2009-09-17 2009-10-28 Martin W J Medicaments
US20130131033A1 (en) * 2010-01-13 2013-05-23 Toyochem Laboratories Pharmaceutical composition for treatment of respiratory tract infections
US11554112B2 (en) 2018-06-07 2023-01-17 Herum Therapeutics International Limited Combinations of β-lactam compounds and probenecid and uses thereof
EA202192193A1 (ru) 2019-02-13 2021-11-09 Итерум Терапьютикс Интернэшнл Лимитед Комбинации бета-лактамных соединений и пробенецида и их применения

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8703360L (sv) * 1987-08-31 1989-03-01 Lejus Medical Ab Granulaera produkter (iii)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2012511572A (ja) * 2008-12-10 2012-05-24 アルファーマ，エルエルシー 動物における病気を制御する組成物および方法

Also Published As

Publication number Publication date
EA199900938A1 (ru) 2000-08-28
AU770024B2 (en) 2004-02-12
CA2291780A1 (en) 1999-10-07
EA002148B1 (ru) 2001-12-24
ID26341A (id) 2000-12-14
AU6415698A (en) 1999-10-18
EP0998295A1 (en) 2000-05-10
AP9901724A0 (en) 1999-12-31
WO1999049875A1 (en) 1999-10-07
UA59394C2 (uk) 2003-09-15

Similar Documents

Publication Publication Date Title
US20220016041A1 (en) Once Daily Formulations Of Tetracyclines
JP3622975B2 (ja) アモキシリンおよびクラブラン酸塩からなるポリマー被覆錠
KR101090719B1 (ko) 프로프라놀롤의 시간조절-지속 방출성 다중-과립형 투여 형태
US4250166A (en) Long acting preparation of cefalexin for effective treatments of bacterial infection sensitive to cefalexin
JPS601128A (ja) 作用持続型セフアクロル製剤
US20110020408A1 (en) multilayered modified release formulation comprising amoxicillin and clavulanate
US20160206564A1 (en) Compositions and methods for treatment and prophylaxis of gastrointestinal diseases
CA2537103A1 (en) Once daily dosage forms of trospium
US6306391B1 (en) Preparation of an oral pharmaceutical formulation containing an anti-infective agent and a microorganism
US8299052B2 (en) Pharmaceutical compositions and methods for improved bacterial eradication
HU184196B (en) Process for producing preparation containing 7-/d-2-amino-2-phenylacetamino/-3-methyl-3-cephem-4-carboxylic acid monohydrate
JP2002516616A (ja) 活性成分として単数または複数の抗感染症薬と微生物とを含む安定な固定薬用量の医薬組成物の製造法
EP1539113A2 (en) Modified release ketoprofen dosage form
WO2008029351A2 (en) A modified release formulation comprising amoxicillin and clavulanate
GB2323532A (en) Pharmaceutical compositions containing an anti-infective agent and a micro-organsim as active ingredients
US20100120896A1 (en) Once-A-Day RNA-Polymerase inhibiting and elongation factor G (EF-G) inhibiting antibiotic pharmaceutical product, formulation thereof, and use thereof in treating infection caused by methicillin-resistant staphylococcus aureus
US20020025309A1 (en) Stable oral pharmaceutical formulation containing an anti-infective agent and a microorganism
AU2006321782B2 (en) Pharmaceutical compositions and methods for improved bacterial eradication
JPS62263124A (ja) 経口投与製剤

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20050218

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20081111

A313 Final decision of rejection without a dissenting response from the applicant

Free format text: JAPANESE INTERMEDIATE CODE: A313

Effective date: 20090401

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20090623